title: Anaphylaxis to ethylene oxide - a rare and overlooked phenomenon?
abstract: Spina bifida patients have been reported to be at increased risk of anaphylactic reactions during general anaesthesia. Following a reaction, latex is often incriminated as spina bifida patients are known to have an increased incidence of latex allergy. Ethylene oxide (EO) has recently been suggested to be an alternative cause, but in many cases reported in the literature, it seems that EO has not been considered as a cause. EO is a highly reactive gas widely used to sterilise heat-sensitive medical devices, and traces of EO can be found in many of the same products as latex. We present the case of a spina bifida patient with a known latex allergy, where EO was found to be the cause of an anaphylactic reaction during general anaesthesia. In addition, we describe measures taken during preparation of a subsequent general anaesthesia to minimise exposure to EO. Spina bifida patients seem to be at increased risk of sensitisation against EO due to repeated exposure, but only limited literature is available. To ensure that EO is considered as a cause in these cases, we recommend that testing for latex and EO go hand in hand following an anaphylactic reaction in this high-risk population.
authors.affiliation: Department of Anaesthesia, Copenhagen University Hospital, Glostrup, Denmark. sbache@webspeed.dk
authors.forename: S
authors.initials: S
authors.lastname: Bache
authors.forename: J T
authors.initials: JT
authors.lastname: Petersen
authors.forename: L H
authors.initials: LH
authors.lastname: Garvey
mesh_terms: D000707:Anaphylaxis / Q000209:etiology*; D000758:Anesthesia / Q000009:adverse effects; D000768:Anesthesia, General; D004202:Disinfectants / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000150:complications*; D005027:Ethylene Oxide / Q000009:adverse effects*; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D020315:Latex Hypersensitivity / Q000150:complications; D018191:Lymphangioma, Cystic / Q000209:etiology / Q000628:therapy; D012086:Reoperation; D012882:Skin Tests; D016135:Spinal Dysraphism / Q000150:complications; D013256:Steroids / Q000627:therapeutic use; D017287:Ventriculoperitoneal Shunt; D055815:Young Adult
chemical_list: D004202:Disinfectants; D006633:Histamine Antagonists; D013256:Steroids; D007073:Immunoglobulin E; D005027:Ethylene Oxide